Medical Literature

Textbook Chapters

Journal Articles

Additional Journal Articles

Requests for copies of recent publications can be made at ibtpp@infantbotulism.org

  • Descriptive epidemiology of infant botulism in California: the first 40 years. Panditrao MV, Dabritz HA, Kazerouni N, Meissinger JK, Arnon SS. 2020.. J Pediatr 227: 247-257.
  • Seven-year case-control study in California of risk factors for infant botulism. Panditrao MV, Dabritz HA, Kazerouni N, Damus K, Meissinger JK, Arnon SS. 2020. J Pediatr 227:258-267.
  • Dual-toxin ("bivalent") infant botulism in California, 1976-2020: epidemiological, clinical and laboratory aspects. Pandiatrao MV, Chung CH, Khouri JM, Barash JR, Motter RN, Dover N, Arnon SS. Dual-toxin ("bivalent") infant botulism in California, 1976-2020: epidemiological, clinical and laboratory aspects. J Pediatr S0022-3476:00725-00729.
  • Molecular characterization of a novel botulinum neurotoxin type H gene. Dover N, Barash JR, Hill KK, Xie G, Arnon SS. 2014. J Infect Dis 209(2):192-202.
  • Closed genome sequence of Clostridium botulinum strain IBCA10-7060 type Bh. Dover N, Barash JR, Bell JM, Sylvester MD, Arnon SS. 2021. Microb Resour Announc 10(34):30038321.
  • Duration of fecal excretion of Clostridium Botulinum and Botulinum Neurotoxin in Patients Recovering from infant Botulism. Dabritz HA, Payne JR, Khouri JM. J. 2023 Pediatr: Online ahead of print: 113396

Official State of California Department of Public Health website